Pancreatic cancer models for translational research

Pharmacol Ther. 2017 May;173:146-158. doi: 10.1016/j.pharmthera.2017.02.013. Epub 2017 Feb 4.

Authors

Diana Behrens¹, Wolfgang Walther², Iduna Fichtner³

Affiliations

¹ EPO - Experimental Pharmacology and Oncology GmbH - GmbH, Robert-Roessle-Str. 10, 13125 Berlin, Germany. Electronic address: Diana.Behrens@epo-berlin.com.
² Experimental and Clinical Research Center (ECRC), Charité, University Medicine, Berlin; Max-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Str. 10, 13125 Berlin, Germany.
³ EPO - Experimental Pharmacology and Oncology GmbH - GmbH, Robert-Roessle-Str. 10, 13125 Berlin, Germany.

PMID: 28174092
DOI: 10.1016/j.pharmthera.2017.02.013

No abstract available

Keywords: Mouse models; Pancreatic cancer; Patient-derived xenografts; Preclinical oncology; Translational research.

Publication types

Review

MeSH terms

Animals
Humans
Pancreatic Neoplasms / pathology*
Translational Research, Biomedical / methods
Xenograft Model Antitumor Assays / methods